Congenital CMV Shows Low Rate of Progression After Age 2 - Medscape
Congenital CMV Shows Low Rate of Progression After Age 2 Medscape May 17, 2012 (Thessaloniki, Greece) ? About 9% of children with congenital cytomegalovirus (CMV) infection develop moderate to severe outcomes; however, only a small percentage of those who are asymptomatic at birth have disease progression after age ...
Clinigen gains US FDA approval for Foscavir in HIV/AIDS-related ... - MarketWatch (press release)
Clinigen gains US FDA approval for Foscavir in HIV/AIDS-related ... MarketWatch (press release) Clinigen Healthcare, the pharmaceutical products division of Clinigen Group, announced today that its supplemental new drug application (sNDA) for Foscavir (foscarnet sodium), a treatment for HIV/AIDS-related cytomegalovirus (CMV) infections and herpes ...
PCR Bests Culture at Identifying Congenital CMV Infections Family Practice News Digital Network BOSTON ? A real-time saliva-based polymerase chain reaction assay identifies more newborns with congenital cytomegalovirus infections than a standard rapid-culture assay, investigators reported. "A PCR [polymerase chain reaction]-based assay would be a ...
FDA Approves Foscarnet for HIV-Related CMV Retinitis, Herpes - Medscape
HIV Drug Safe During Pregnancy dailyRx The virus destroys CD4+ white blood cells and opens the body up to diseases and infections that the body would normally be able to fight off (pneumocystis pneumonia, cytomegalovirus, fungal infections, toxoplasmosis) and rare cancers (Kaposi's sarcoma, ...
Women & Infants Participating in Study of Treatment of Common Viral Infection ... - PR.com (press release)
Women & Infants Participating in Study of Treatment of Common Viral Infection... PR.com (press release) Providence, RI, April 25, 2012 --(PR.com)-- Women & Infants Hospital of Rhode Island, through its participation in the Maternal-Fetal Medicine Units Network, has been named the lead center in a 14-site, $25 million study of cytomegalovirus (CMV), ...
Pills That Prevents HIV? dailyRx For decades, researchers have struggled to find medical defenses against HIV infection. Now, an effective option is on the table: Popping a preventative pill called Truvada. Truvada, if approved by the US Food and Drug Administration (FDA), ...
Targeted Therapies in the Management of Leukemia and Lymphoma - Cancer Network
Targeted Therapies in the Management of Leukemia and Lymphoma Cancer Network Reactivation of herpes virus infections, including cytomegalovirus (CMV), represents the most common opportunistic infection in patients receiving alemtuzumab. Patients should receive prophylaxis against opportunistic infections and be monitored for ...
Successful Immunization and Safety Documented in Nasal Administration Study of ... - MarketWatch (press release)
Successful Immunization and Safety Documented in Nasal Administration Study of ... MarketWatch (press release) These results support that immunization of HIV-infected individuals by nasal co-administration of Vacc-4x and Endocine adjuvant is safe and is able to strengthen vaccine related immune responses. About the HIV vaccine Vacc-4x Vacc-4x is a therapeutic ...
Women & Infants participating in study of treatment of common viral infection ... - FirstScience
Women & Infants participating in study of treatment of common viral infection... FirstScience ... $25 million study of cytomegalovirus (CMV), the most common infection during pregnancy. Researchers want to see whether giving recently infected pregnant women antibodies against CMV lowers the rate of CMV infection in their babies.
What our clients and candidates are saying about us: The website looks great. You truly are the best! - recruiter that is. Thanks for the outstanding referral. Am very happy in new position. - Terri
The #1 Resource for professionals in the Pharmaceutical Advertising, Medical Communications, Healthcare Public Relations, Pharmaceutical Industry, and Biotechnology fields since 1988.